CA
TNDM icon

CoreCap Advisors’s Tandem Diabetes Care TNDM Stock Holding History

CoreCap Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Sell
1,164
-119
-9% -$2.08K ﹤0.01% 1854
2026
Q1 		$24.6K Sell
1,283
-4,626
-78% -$101K ﹤0.01% 1591
2025
Q4 		$130K Buy
5,909
+1,158
+24% +$20.9K ﹤0.01% 938
2025
Q3 		$57.7K Buy
4,751
+3,468
+270% +$46.9K ﹤0.01% 1258
2025
Q2 		$23.9K Hold
1,283
– – ﹤0.01% 1540
2025
Q1 		$24.6K Hold
1,283
– – ﹤0.01% 1454
2024
Q4 		$46.2K Hold
1,283
– – ﹤0.01% 1213
2024
Q3 		$54.4K Buy
+1,283
New +$54.4K ﹤0.01% 1149
2024
Q2 		– Sell
-1,053
Closed -$37.3K – 2488
2024
Q1 		$37.3K Buy
+1,053
New +$28.2K ﹤0.01% 1226
2022
Q4 		$49.7K Buy
+1,106
New +$50.1K ﹤0.01% 990
2022
Q3 		– Sell
-1,032
Closed -$61K – 1949
2022
Q2 		$61K Buy
+1,032
New +$84.7K ﹤0.01% 875
2022
Q1 		– Sell
-1,432
Closed -$216K – 1952
2021
Q4 		$216K Buy
+1,432
New +$193K 0.01% 520

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

CoreCap Advisors's TNDM Position: Q2 2026 in Review

CoreCap Advisors reduced its Tandem Diabetes Care (TNDM) stake by 9.3% in Q2 2026, selling an estimated $2.08K and leaving 1,164 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1854.

CoreCap Advisors first reported a position in TNDM in Q4 2021 and has held it in 12 quarters since. The position peaked at $216K in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • CoreCap Advisors held 1,164 shares of Tandem Diabetes Care worth $17.6K as of Q2 2026.
  • CoreCap Advisors sold 119 Tandem Diabetes Care shares in Q2 2026, an estimated $2.08K.
  • Tandem Diabetes Care made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1854 holding.
  • CoreCap Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Tandem Diabetes Care position peaked at $216K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.